Position in LH
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$9,049,600
+$931,906 QoQ
Shares Held
32,320
+6.2% QoQ
Ownership
0.040%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#184
of 1,040 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Cetera Investment Advisers holds $179,401,377 across 25 Diagnostics & Research names. LH ranks #5 (5.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
109,972 | $55,135,561 | |
| 2 | DHR |
Danaher Corp /De/
|
139,533 | $26,578,245 | |
| 3 | IQV |
Iqvia Holdings Inc.
|
117,365 | $22,677,265 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
22,840 | $12,023,889 | |
| 5 | LH |
Labcorp Holdings Inc.
This page
|
32,320 | $9,049,600 | |
| 6 | DGX |
Quest Diagnostics Inc
|
39,616 | $8,396,611 | |
| 7 | NTRA |
Natera, Inc.
|
27,675 | $7,512,378 | |
| 8 | A |
Agilent Technologies, Inc.
|
48,741 | $6,474,267 |
All Filings in LH
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,049,600 | 32,320 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $8,117,694 | 30,425 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $7,141,550 | 28,466 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $6,848,964 | 23,859 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $5,157,796 | 19,648 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $4,635,249 | 19,916 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $3,773,001 | 16,453 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,385,945 | 15,151 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $2,900,221 | 14,251 | Shares | Sole | 2024-08-22 | |
| No filing history on record for this holder in this stock. | ||||||